METHYLAX 2 G / 10.2 G
METHYLCELLULOSE : 2 G / 10.2 G · DIN 02248253 · SEAFORD PHARMACEUTICALS INC
Health Canada status: APPROVED
What is METHYLAX?
METHYLAX 2 G / 10.2 G contains METHYLCELLULOSE : 2 G / 10.2 G. It is listed in the Health Canada Drug Product Database under DIN 02248253, held by SEAFORD PHARMACEUTICALS INC, supplied as POWDER for ORAL administration. Health Canada currently lists it as approved, status dated 30-Sep-2003. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02248253 |
|---|---|
| Brand name | METHYLAX |
| Generic / active ingredient | METHYLCELLULOSE : 2 G / 10.2 G |
| Manufacturer | SEAFORD PHARMACEUTICALS INC |
| Strength | 2 G / 10.2 G |
| Dosage form | POWDER |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A06AC06 METHYLCELLULOSE |
| AHFS class | 40:34.00* ; See footnote |
| Biosimilar | No |
| Health Canada status | APPROVED |
| Status date | 30-Sep-2003 |
| Original market date | 2005-05-01 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code A06AC06 METHYLCELLULOSE. 0 of 6 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ENTROCEL SOLUTION 1.8% | 1.8 % | SOLUTION | TYCO HEALTHCARE | CANCELLED POST MARKET | DIN 00750700 |
| PRODIEM BULK FIBRE THERAPY POWDER | 2 G / 19 G | POWDER | NOVARTIS CONSUMER HEALTH CANADA INC. | CANCELLED POST MARKET | DIN 02248225 |
| PRODIEM BULK FIBRE THERAPY POWDER SUGAR FREE | 2 G / 10.2 G | POWDER | NOVARTIS CONSUMER HEALTH CANADA INC. | CANCELLED POST MARKET | DIN 02248226 |
| RESTORAFIBRE CAPLET | 500 MG | TABLET | BAYER INC | APPROVED | DIN 02461137 |
| RESTORAFIBRE POWDER SUGAR FREE | 2 G / 10.2 G | POWDER | BAYER INC | APPROVED | DIN 02461145 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.